Synairgen (SNG) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Nov 2009 01:24 PM
RNS
Result of AGM
09 Nov 2009 07:00 AM
RNS
activity of interferon beta a
26 Oct 2009 07:00 AM
RNS
Notice of Investor Conference
14 Oct 2009 02:35 PM
RNS
Notice of Annual Report and A
08 Sep 2009 11:25 AM
RNS
Grant of Options
04 Sep 2009 07:00 AM
RNS
Directorate Changes
04 Sep 2009 07:00 AM
RNS
US Patent Granted
04 Sep 2009 07:00 AM
RNS
Final Results
02 Sep 2009 07:00 AM
RNS
Notice of Results
17 Jul 2009 03:00 PM
RNS
Holding(s) in Company
30 Jun 2009 09:56 AM
RNS
Total Voting Rights
25 Jun 2009 02:36 PM
RNS
Holding(s) in Company
23 Jun 2009 07:00 AM
RNS
Holding(s) in Company
15 Jun 2009 11:06 AM
RNS
Second Closing of the Fundrai
12 Jun 2009 11:22 AM
RNS
Result of General Meeting
27 May 2009 07:00 AM
RNS
Fundraising Announcement
01 Apr 2009 07:00 AM
RNS
Preliminary biomarker data
31 Mar 2009 07:00 AM
RNS
Change of Adviser
26 Mar 2009 07:00 AM
RNS
Half Yearly Results
24 Mar 2009 11:14 AM
RNS
Notice of Results
17 Mar 2009 07:00 AM
RNS
Progress update: Clinical Tri
13 Nov 2008 12:15 PM
RNS
Result of AGM
07 Nov 2008 03:25 PM
RNS
Change of NOMAD
31 Oct 2008 09:00 AM
RNS
Total Voting Rights
20 Oct 2008 07:00 AM
RNS
Director/PDMR Shareholding an
10 Oct 2008 01:53 PM
RNS
Posting of 2008 Annual Report
08 Oct 2008 09:12 AM
RNS
Change of Adviser Name
22 Sep 2008 07:00 AM
RNS
Research Update
04 Aug 2008 10:00 AM
RNS
Director/PDMR Shareholding
31 Jul 2008 07:00 AM
RNS
Final Results
29 Jul 2008 07:00 AM
RNS
Commencement of Clinical Tria
14 Jul 2008 11:48 AM
RNS
Notice of Results
23 May 2008 07:00 AM
RNS
Presentation of data at ATS
13 Mar 2008 07:01 AM
RNS
Director Shareholding
12 Mar 2008 07:01 AM
RNS
Interim Results
25 Feb 2008 07:01 AM
RNS
Notice of Results
11 Feb 2008 07:01 AM
RNS
Patent Granted
12 Dec 2007 07:01 AM
RNS
Research Collaboration
15 Nov 2007 07:01 AM
RNS
Result of AGM
12 Nov 2007 08:25 AM
RNS
Contract with Alpha Biologics
31 Oct 2007 12:45 PM
RNS
Director/PDMR Shareholding
28 Sep 2007 07:04 AM
RNS
Licence/ Supply by Rentschler
26 Sep 2007 07:01 AM
RNS
Final Results
20 Aug 2007 07:00 AM
RNS
Notice of Preliminary Results
17 Aug 2007 01:52 PM
RNS
AIM Rule 26
16 Aug 2007 02:54 PM
RNS
Change of Adviser
28 Jun 2007 02:30 PM
RNS
Director/PDMR Shareholding
12 Jun 2007 07:01 AM
RNS
Research Update
20 Mar 2007 04:07 PM
RNS
Holding(s) in Company
19 Mar 2007 07:00 AM
RNS
Interim Results

Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic.

Synairgen is a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta candidate (SNG001) for severe viral lung infections.

Synairgen share price launched at 155p in 2004.

UK 100

Latest directors dealings